Human High Mobility Group Box 1 (HMGB1)

<strong>Human High Mobility Group Box 1 (HMGB1)</strong>_x000D_ <strong>Catalog number:</strong> B2018554_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~35 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> HMGB1_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Vijayakumar EC, Bhatt LK, Prabhavalkar KS. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics Curr Drug Targets. 2019;20(14):1474-1485._x000D_ 2: Rapoport BL, Steel HC, Theron AJ, Heyman L, Smit T, Ramdas Y, Anderson R. High Mobility Group Box 1 in Human Cancer Cells. 2020 Jul 10;9(7):1664._x000D_ 3: Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L, Habotta OA, Batiha GE. High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons Inflammopharmacology. 2022 Jun;30(3):811-820._x000D_ 4: DeWulf B, Minsart L, Verdonk F, Kruys V, Piagnerelli M, Maze M, Saxena S. High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy Cells. 2023 Apr 4;12(7):1088._x000D_ 5: Teo Hansen Selnø A, Schlichtner S, Yasinska IM, Sakhnevych SS, Fiedler W, Wellbrock J, Berger SM, Klenova E, Gibbs BF, Fasler-Kan E, Sumbayev VV. High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells Front Immunol. 2021 Jun 21;12:675731._x000D_ 6: Yuan S, Liu Z, Xu Z, Liu J, Zhang J. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies J Hematol Oncol. 2020 Jul 13;13(1):91._x000D_ 7: Paudel YN, Angelopoulou E, C BK, Piperi C, Othman I. High mobility group box 1 (HMGB1) protein in Multiple Sclerosis (MS): Mechanisms and therapeutic potential Life Sci. 2019 Dec 1;238:116924._x000D_ 8: Gillespie KP, Pirnie R, Mesaros C, Blair IA. Cisplatin Dependent Secretion of Immunomodulatory High Mobility Group Box 1 (HMGB1) Protein from Lung Cancer Cells Biomolecules. 2023 Aug 31;13(9):1335._x000D_ 9: Chen R, Zou J, Kang R, Tang D. The Redox Protein High-Mobility Group Box 1 in Cell Death and Cancer Antioxid Redox Signal. 2023 Sep;39(7-9):569-590._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/29745087">10: Suren D, Arda Gokay A, Sayiner A. High Mobility Group Box 1 (HMGB1) expression in gastric adenocarcinomas J BUON. 2018 Mar-Apr;23(2):422-427.</a>_x000D_ _x000D_ <strong>Products Related to Human High Mobility Group Box 1 (HMGB1) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>